Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Staidson (beijing) Biopharmaceuticals Co., Ltd

Clinical trials sponsored by Staidson (beijing) Biopharmaceuticals Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to tame rare blood vessel disease Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 4 Completed 1

New eye drop shows promise for rare corneal disease

Disease control Completed

This early-stage trial tested an experimental eye drop called STSP-0902 in 82 healthy volunteers to see if it is safe and how the body processes it. The study involved single and multiple doses, with some participants getting a placebo. The goal is to eventually treat neurotrophi…

Phase 1 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC